Nu Skin Enterprises Inc. | Small-cap | Consumer Defensive
$12.13
6.59%
| Nu Skin Enterprises Stock Comparison:
Nu Skin Enterprises vs Procter & GambleNu Skin Enterprises vs Colgate-PalmoliveNu Skin Enterprises vs Spectrum BrandsNu Skin Enterprises vs Edgewell PersonalNu Skin Enterprises vs Yatsen HoldingNu Skin Enterprises vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 364.5M
Gross Profit 247.0M 67.76%
Operating Income 15.2M 4.17%
Net Income 107.5M 29.50%
EPS (Diluted) $2.14

Balance Sheet Metrics

Total Assets 1.4B
Total Liabilities 637.4M
Shareholders Equity 754.0M
Debt to Equity 0.85

Cash Flow Metrics

Operating Cash Flow 130.7M
Free Cash Flow -13.2M

Revenue & Profitability Trend

Nu Skin Enterprises Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i1.7B2.0B2.2B2.7B2.6B
Cost of Goods Sold i550.2M611.8M630.9M675.2M658.0M
Gross Profit i1.2B1.4B1.6B2.0B1.9B
Gross Margin % i68.2%68.9%71.7%75.0%74.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i1.1B1.3B1.4B1.7B1.7B
Other Operating Expenses i-----
Total Operating Expenses i1.1B1.3B1.4B1.7B1.7B
Operating Income i50.8M68.1M159.3M285.9M257.6M
Operating Margin % i2.9%3.5%7.2%10.6%10.0%
Non-Operating Items
Interest Income i-----
Interest Expense i26.4M----
Other Non-Operating Income-199.4M-41.5M-70.4M-53.4M-1.3M
Pre-tax Income i-175.1M26.6M89.0M232.5M256.2M
Income Tax i-28.5M18.0M-15.8M85.2M64.9M
Effective Tax Rate % i0.0%67.7%-17.8%36.6%25.3%
Net Income i-146.6M8.6M104.8M147.3M191.4M
Net Margin % i-8.5%0.4%4.7%5.5%7.4%
Key Metrics
EBITDA i123.5M158.8M280.3M414.1M331.6M
EPS (Basic) i$-2.95$0.17$2.10$2.93$3.66
EPS (Diluted) i$-2.95$0.17$2.07$2.86$3.63
Basic Shares Outstanding i4966200049711000500020005019300052296000
Diluted Shares Outstanding i4966200049711000500020005019300052296000

Income Statement Trend

Nu Skin Enterprises Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i186.9M256.1M264.7M339.6M402.7M
Short-term Investments i11.1M11.8M13.8M15.2M21.2M
Accounts Receivable i50.8M72.9M47.4M41.3M63.4M
Inventory i190.2M280.0M346.2M399.9M314.4M
Other Current Assets13.7M17.9M18.4M17.6M14.7M
Total Current Assets i538.6M701.9M759.9M873.0M903.2M
Non-Current Assets
Property, Plant & Equipment i82.1M101.3M113.0M127.4M164.5M
Goodwill i241.5M566.8M479.6M489.9M495.5M
Intangible Assets i74.3M105.3M66.7M77.0M89.5M
Long-term Investments03.7M10.6M6.0M-
Other Non-Current Assets265.9M185.5M166.2M110.0M96.6M
Total Non-Current Assets i930.3M1.1B1.1B1.0B1.1B
Total Assets i1.5B1.8B1.8B1.9B2.0B
Liabilities
Current Liabilities
Accounts Payable i34.9M43.5M54.0M50.0M66.2M
Short-term Debt i47.9M48.9M54.4M140.9M75.0M
Current Portion of Long-term Debt-----
Other Current Liabilities13.9M6.3M---
Total Current Liabilities i296.6M328.9M359.2M529.7M542.9M
Non-Current Liabilities
Long-term Debt i430.3M558.4M466.1M362.9M425.4M
Deferred Tax Liabilities i39.9M35.5M36.0M24.2M23.4M
Other Non-Current Liabilities7.5M9.0M11.9M17.4M16.9M
Total Non-Current Liabilities i520.9M655.6M564.4M464.0M519.9M
Total Liabilities i817.5M984.5M923.7M993.7M1.1B
Equity
Common Stock i91.0K91.0K91.0K91.0K91.0K
Retained Earnings i1.7B1.9B1.9B1.9B1.8B
Treasury Stock i1.6B1.6B1.6B1.5B1.5B
Other Equity-----
Total Shareholders Equity i651.5M822.0M897.3M912.8M894.3M
Key Metrics
Total Debt i478.2M607.3M520.5M503.8M500.4M
Working Capital i242.0M373.0M400.6M343.3M360.3M

Balance Sheet Composition

Nu Skin Enterprises Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-146.6M8.6M104.8M147.3M191.4M
Depreciation & Amortization i69.8M70.9M72.5M76.3M74.0M
Stock-Based Compensation i14.8M15.6M12.4M23.2M24.1M
Working Capital Changes i-1.3M-50.3M-17.9M-135.1M-52.0M
Operating Cash Flow i-92.2M60.1M164.7M166.2M271.7M
Investing Activities
Capital Expenditures i-41.6M-58.5M-59.1M-68.6M-63.8M
Acquisitions i0-77.3M0-19.0M-14.9M
Investment Purchases i-14.8M-16.9M-14.0M-16.2M-14.7M
Investment Sales i18.4M18.1M5.9M15.1M14.0M
Investing Cash Flow i-38.0M-134.5M-67.1M-88.7M-79.4M
Financing Activities
Share Repurchases i0-13.0M-70.0M-80.4M-144.3M
Dividends Paid i-11.9M-77.6M-77.0M-76.3M-78.4M
Debt Issuance i15.0M110.0M460.0M155.0M115.0M
Debt Repayment i-127.9M-13.2M-434.4M-116.9M-143.2M
Financing Cash Flow i-131.1M6.2M-126.6M-118.6M-250.9M
Free Cash Flow i70.2M60.1M49.0M73.0M315.3M
Net Change in Cash i-261.2M-68.3M-29.0M-41.0M-58.7M

Cash Flow Trend

Nu Skin Enterprises Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 5.78
Forward P/E 11.28
Price to Book 0.74
Price to Sales 0.36
PEG Ratio -0.05

Profitability Ratios

Profit Margin 6.20%
Operating Margin 7.97%
Return on Equity 13.68%
Return on Assets 3.95%

Financial Health

Current Ratio 2.01
Debt to Equity 43.06
Beta 0.89

Per Share Data

EPS (TTM) $2.03
Book Value per Share $15.91
Revenue per Share $32.75

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
nus580.6M5.780.7413.68%6.20%43.06
Procter & Gamble 371.0B24.337.2431.24%18.95%69.86
Colgate-Palmolive 68.8B23.9097.89398.04%14.54%832.51
Spectrum Brands 1.4B25.180.733.01%2.56%40.13
Edgewell Personal 1.1B17.440.704.12%2.94%90.06
Yatsen Holding 874.2M-0.28-16.53%-17.05%5.13

Financial data is updated regularly. All figures are in the company's reporting currency.